Dr. Matthew Robison, DO
OB-GYN (Obstetrics & Gynecology) (Obstetrics & Gynecology Physician)
3450 Potomac Way
Idaho Falls, ID 83404
Who else practices at this address →
Bonneville County includes primary care (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- At Still University of Health Sciences, College of Osteo Med, Kirksville (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 79
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: At Still University of Health Sciences, College of Osteo Med, Kirksville
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Obstetrics & Gynecology Physician primary
ID license O-0646 · MI license 5101016745
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: OB-GYN (Obstetrics & Gynecology) per capita by county →
Where they work
Hospitals
- Mountain View Hospital Idaho Falls, ID
Medical groups
- Women's Healthcare Associates, P.a. (14 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 79
- Services billed
- 200
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Insertion of needle into vein for collection of blood sample | 55 | 48 |
| Established patient office or other outpatient visit, 20-29 minutes | 31 | 29 |
| Dxa bone density measurement of hip, pelvis, spine | 29 | 29 |
| Automated urinalysis test | 20 | 18 |
| Established patient office or other outpatient visit, 30-39 minutes | 13 | 11 |
| Established patient office or other outpatient visit, 10-19 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Estradiol Other prescribers in Idaho Falls, ID | 27 |
| Dicyclomine Hcl Other prescribers in Idaho Falls, ID | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 20 payments worth $1,223 in total to this clinician.
| Medtronic, Inc. | $1,074 |
|---|---|
| Astellas Pharma US Inc | $56.37 |
| AbbVie Inc. | $36.69 |
| Sumitomo Pharma America, Inc. | $26.54 |
| Daiichi Sankyo Inc. | $14.62 |
| Novo Nordisk Inc | $14.38 |
| Travel and Lodging | $973 |
|---|---|
| Food and Beverage | $249 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Nov 12, 2025 | Travel and Lodging INTERSTIM · Sacral Nerve Stimulation · travel to Dallas, TX · in-kind | $886 |
| Medtronic, Inc. Dec 8, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $52.27 |
| Medtronic, Inc. Nov 12, 2025 | Travel and Lodging INTERSTIM · Sacral Nerve Stimulation · travel to Dallas, TX · in-kind | $35.07 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $5,058 in research payments for these studies, mostly to the institutions running them.
- A Phase IV, Longitudinal, Observational Study Examining Real-World Outcomes of Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vasomotor Symptoms
Astellas Pharma Global Development
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.